|
Report Date : |
17.05.2013 |
IDENTIFICATION DETAILS
|
Name : |
Arab company for Gelatin and Pharmaceuticals
Products (Arab caps) |
|
|
|
|
Registered Office : |
El Nassereya
Industrial Zone, Amreya, Alexandria |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Year of Establishment : |
1983 |
|
|
|
|
Com. Reg. No.: |
109983,
Alexandria |
|
|
|
|
Legal Form : |
Egyptian Joint
Stock Company |
|
|
|
|
Line of Business : |
Manufacture of capsules and gelatine products used in the pharmaceutical industry |
|
|
|
|
No. of Employees : |
450 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made on
e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Egypt |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EGYPT - ECONOMIC OVERVIEW
Occupying the northeast corner of the African continent,
Egypt is bisected by the highly fertile Nile valley, where most economic
activity takes place. Egypt's economy was highly centralized during the rule of
former President Gamal Abdel NASSER but opened up considerably under former
Presidents Anwar EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008
aggressively pursued economic reforms to attract foreign investment and
facilitate GDP growth. Despite the relatively high levels of economic growth in
recent years, living conditions for the average Egyptian remained poor and
contributed to public discontent. After unrest erupted in January 2011, the
Egyptian Government backtracked on economic reforms, drastically increasing
social spending to address public dissatisfaction, but political uncertainty at
the same time caused economic growth to slow significantly, reducing the
government's revenues. Tourism, manufacturing, and construction were among the
hardest hit sectors of the Egyptian economy, and economic growth is likely to
remain slow during the next several years. The government drew down foreign
exchange reserves by more than 50% in 2011 and 2012 to support the Egyptian
pound and the dearth of foreign financial assistance - as a result of unsuccessful
negotiations with the International Monetary Fund over a multi-billion dollar
loan agreement which have dragged on more than 20 months - could precipitate
fiscal and balance of payments crises in 2013.
Source
: CIA
Company Name :
ARAB COMPANY FOR GELATIN AND PHARMACEUTICAL
PRODUCTS (ARAB CAPS)
Country of Origin : Egypt
Legal Form :
Egyptian Joint Stock Company
Registration Date : 1983
Commercial
Registration Number : 109983,
Alexandria
Industry
Registration Number :
133880
Tax Card Number : 100-135-404
Chamber Licence
Number : 0623
Issued Capital : £E
35,000,000
Paid up Capital : £E
35,000,000
Total Workforce : 450
Activities :
Manufacture of capsules and gelatine products used in the pharmaceutical industry
Financial Condition : Fair
Payments :
Nothing detrimental uncovered
Operating Trend : Steady
ARAB COMPANY FOR
GELATIN AND PHARMACEUTICAL PRODUCTS (ARAB CAPS)
Location : El Nassereya Industrial Zone,
Amreya
Town : Alexandria
Country : Egypt
Telephone : (20-3) 4480101 / 4480102 / 4481511 /
5799385
Facsimile : (20-3) 4480807 / 4765907
Mobile : (20-100) 1643200
Email : arabcaps@alexcomm.net
Subject operates
from a large suite of offices and a factory that are rented and located in the
Industrial Area of Alexandria.
Branch Office
(s)
Location Description
·
14
Sayed Darwesh Office
premises
Tawfikeya
Cairo
Tel: (20-2) 25787601 / 25765907 / 25799385
Fax: (20-2) 25765907
Name Position
·
Mamdouh
Abbass Chairman
·
Ahmed
Mamdouh Hamed Director
·
Dr
Gamal El Din Mahmoud Ghaly Director
·
Adel
Ahmed Adel Director
·
Adel Abd
El Halim Moustafa Director
·
Mona
Mohamed Ayed Tolba Director
·
Dr
Magdy Hassan Ahmed Director
·
Dr
Salah Medhat Salah El Din El Sharawy Director
·
Dr
Mamdouh Abbass Mohamed Ibrahim Director
·
Dr Mamdouh
Abd El Razek Moustafa Director
·
Ayman
Mohamed Ezzat Cairo
Branch Manager
·
Hady
Zaki Finance
Manager
·
Hossam
Atta Accounts
Manager
·
Ahlam
Mahmoud Production
Manager
·
Manal
Soukarah Quality
Manager
·
Read El
Shamy Purchasing
Manager
Date of Establishment : 1983
Legal Form :
Egyptian Joint Stock
Company
Commercial Reg. No. : 109983,
Alexandria
Industry
Reg. No. : 133880
Tax
Card No. : 100-135-404
Chamber
Lic. No. : 0623
Issued Capital : £E 35,000,000
Paid up Capital : £E 35,000,000
·
Acdima
Arab for Drugs Industries and Medical
Appliances 76.80%
Kuwait
·
Holding
for Pharmaceuticals Chemicals and Medical Appliances (Holdi Pharma) 18.70%
Egypt
·
Nile Pharmaceuticals
and Chemicals Industries 1.40%
Egypt
·
Cairo
Pharmaceuticals and Chemicals Industries 1.40%
Egypt
·
Arab
Drugs and Chemical Industries ADCO 1.40%
Egypt
·
El
Gomhouria for Trading Pharmaceuticals, Chemicals & Medical Appliances
0.15%
Egypt
·
CID
Pharmaceuticals Chemical Industries Development 0.15%
Egypt
Activities: Engaged
in the manufacture of capsules and gelatine products used in the pharmaceutical industry.
Subject is ISO 9002:14001:18001 accredited.
Import
Countries: France and Germany.
Export
Countries: Syria, Sudan, Yemen and Saudi Arabia.
Operating Trend: Steady
Subject has a
workforce of approximately 450 employees.
Financial highlights
provided by local sources are given below:
Currency: Egyptian
Pounds (£E)
Year Ending 31/12/11: Year Ending 31/12/12:
Total Sales £E 75,000,000 £E 82,000,000
Local sources
consider subject’s financial condition to be Fair.
The above financial
figures are based on estimations by our local sources.
·
Banque
Misr
151 Mohamed Farid Street
Cairo
Tel: (20-2) 33912711 / 33912106
Fax: (20-2) 33919779
·
14 Wadi
El Nile Street
Nahda Square
Maadi
PO Box: 249
Cairo
Tel: (20-2) 33582681
Fax: (20-2) 33582274
·
Citibank
PO Box: 188
Cairo
Tel: (20-2) 33551877 / 33551874
Fax: (20-2) 33558056
No complaints
regarding subject’s payments have been reported.
During the course of
this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the
company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.77 |
|
|
1 |
Rs.83.31 |
|
Euro |
1 |
Rs.70.46 |
INFORMATION DETAILS
|
Report
Prepared by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.